BRIEF-CM Enel-Med signs LOI to buy stake in three medical units
* SIGNS LOI ON BUYING STAKES IN THREE MEDICAL UNITS OPERATING IN WARSAW FOR UP TO 3.0 MILLION ZLOTYS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Oct 4 OSE Immunotherapeutics SA :
* To present the preclinical data of its new checkpoint inhibitor EFFI-dem on SIRP-/cd47 strategic pathway at the 2016 immune checkpoint inhibitors conference Source text for Eikon: Further company coverage: (Gdynia Newsroom)
ZURICH, June 23 A European Medicines Agency (EMA) panel recommended on Friday approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance against tough-to-treat breast cancer.